We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

103 hedge funds and large institutions have $185M invested in Antares Pharma, Inc. in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more call options, than puts

Call options by funds: $640K | Put options by funds: $176K

112% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 17

61% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 18

30% more capital invested

Capital invested by funds: $142M → $185M (+$43.3M)

21% more funds holding

Funds holding: 85 → 103 (+18)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
103
Holders Change
+18
Holders Change %
+21.18%
% of All Funds
2.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
36
Increased
29
Reduced
18
Closed
17
Calls
$640K
Puts
$176K
Net Calls
+$464K
Net Calls Change
+$222K

Top Buyers

1
BlackRock
BlackRock
New York
+$17.8M
2
State Street
State Street
Massachusetts
+$5.54M
3
Northern Trust
Northern Trust
Illinois
+$3.88M
4
PA
Perceptive Advisors
New York
+$3.83M
5
Deutsche Bank
Deutsche Bank
Germany
+$2.45M

Top Sellers

1
AC
Armistice Capital
New York
-$8.5M
2
BC
Broadfin Capital
New York
-$8.05M
3
Millennium Management
Millennium Management
New York
-$5.07M
4
KCM
Kingdon Capital Management
New York
-$2.41M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$29.6M +$17.8M +6,286,030 +217%
Vanguard Group
2
Vanguard Group
Pennsylvania
$19.9M +$1.61M +567,144 +10%
AC
3
Armistice Capital
New York
$18.4M -$8.5M -3,000,000 -34%
BC
4
Broadfin Capital
New York
$15.5M -$8.05M -2,838,678 -37%
PA
5
Perceptive Advisors
New York
$13.7M +$3.83M +1,350,000 +46%
Renaissance Technologies
6
Renaissance Technologies
New York
$11.1M +$878K +309,900 +10%
RCMNY
7
Rubric Capital Management (New York)
New York
$10.3M +$2.31M +816,630 +34%
State Street
8
State Street
Massachusetts
$6.53M +$5.54M +1,954,769 +2,682%
JAM
9
JW Asset Management
Florida
$5.38M +$1.03M +362,431 +28%
Northern Trust
10
Northern Trust
Illinois
$5.33M +$3.88M +1,368,131 +478%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$3.83M +$657K +231,904 +24%
Wells Fargo
12
Wells Fargo
California
$3.35M +$775K +273,496 +36%
Deutsche Bank
13
Deutsche Bank
Germany
$3.23M +$2.45M +866,168 +626%
KCM
14
Kingdon Capital Management
New York
$3.05M -$2.41M -851,508 -47%
California Public Employees Retirement System
15
California Public Employees Retirement System
California
$3.01M – – –
Allianz Asset Management
16
Allianz Asset Management
Germany
$2.49M +$2.19M +773,838 New
Fuller & Thaler Asset Management
17
Fuller & Thaler Asset Management
California
$2.36M -$7.37K -2,600 -0.4%
Morgan Stanley
18
Morgan Stanley
New York
$1.74M -$1.3M -457,189 -46%
Charles Schwab
19
Charles Schwab
California
$1.72M +$693K +244,483 +85%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$1.69M +$1.01M +357,991 +214%
GC
21
Guggenheim Capital
Illinois
$1.3M +$1.14M +403,975 New
Millennium Management
22
Millennium Management
New York
$1.27M -$5.07M -1,789,533 -82%
TCIM
23
TIAA CREF Investment Management
New York
$1.25M +$1.1M +388,355 New
Goldman Sachs
24
Goldman Sachs
New York
$1.22M -$558K -197,022 -34%
AC
25
Avenir Corporation
Virginia
$1.13M +$85.5K +30,150 +9%
1
2 3 4 5

ATRS Hedge Fund Activity: Q2 2017 in Review

103 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q2 2017, worth a combined $185M — up 30% from $142M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ATRS positions and 17 closed out — a net gain of 19 holders — while 29 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $17.8M. The largest seller was Armistice Capital, cutting an estimated $8.5M.

  • 103 institutional investors held Antares Pharma, Inc. (ATRS) as of Q2 2017, up from 85 in Q1 2017.
  • Funds reported $185M of Antares Pharma, Inc. stock for Q2 2017, up 30% quarter-over-quarter.
  • 36 funds opened new Antares Pharma, Inc. positions in Q2 2017 and 17 closed out, a net change of +19 holders.
  • The largest Antares Pharma, Inc. buyer in Q2 2017 was BlackRock, an estimated $17.8M added.
  • The largest Antares Pharma, Inc. seller in Q2 2017 was Armistice Capital, an estimated $8.5M sold.

Based on aggregated 13F filings for Q2 2017.